243 related articles for article (PubMed ID: 17657602)
21. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
22. High-cost life prolongation: the National Kidney Dialysis and Kidney Transplantation Study.
Gutman RA
Ann Intern Med; 1988 Jun; 108(6):898-9. PubMed ID: 3285750
[No Abstract] [Full Text] [Related]
23. The organization and funding of the treatment of end-stage renal disease in Australia.
Harris A
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):113-32. PubMed ID: 17763938
[TBL] [Abstract][Full Text] [Related]
24. The American health care system. The End Stage Renal Disease Program.
Iglehart JK
N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
[No Abstract] [Full Text] [Related]
25. A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies.
van der Tol A; Stel VS; Jager KJ; Lameire N; Morton RL; Van Biesen W; Vanholder R
Nephrol Dial Transplant; 2020 Jun; 35(6):979-986. PubMed ID: 32227227
[TBL] [Abstract][Full Text] [Related]
26. Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.
Van Biesen W; Lameire N; Peeters P; Vanholder R
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):133-48. PubMed ID: 17638074
[TBL] [Abstract][Full Text] [Related]
27. Cost analysis of alternative treatments in end-stage renal disease.
Karlberg I
Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
[No Abstract] [Full Text] [Related]
28. Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS).
Satayathum S; Pisoni RL; McCullough KP; Merion RM; Wikström B; Levin N; Chen K; Wolfe RA; Goodkin DA; Piera L; Asano Y; Kurokawa K; Fukuhara S; Held PJ; Port FK
Kidney Int; 2005 Jul; 68(1):330-7. PubMed ID: 15954924
[TBL] [Abstract][Full Text] [Related]
29. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
[TBL] [Abstract][Full Text] [Related]
30. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
31. End-stage renal disease in India and Pakistan: burden of disease and management issues.
Sakhuja V; Sud K
Kidney Int Suppl; 2003 Feb; (83):S115-8. PubMed ID: 12864888
[TBL] [Abstract][Full Text] [Related]
32. The dilemmas of patient treatment for end-stage renal disease.
Schmidt RW; Blumenkrantz M; Wiegmann TB
Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
[TBL] [Abstract][Full Text] [Related]
33. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
[TBL] [Abstract][Full Text] [Related]
34. Kidneys, ethics, and politics: policy lessons of the ESRD experience.
Caplan AL
J Health Polit Policy Law; 1981; 6(3):488-503. PubMed ID: 7033349
[TBL] [Abstract][Full Text] [Related]
35. Funding ESRD care through charity: the paradigm of the National Kidney Foundation of Singapore.
Ramirez SP; Hsu SI; Nandakumar M; Friedman EA; Durai TT; Owen WF
Semin Nephrol; 2001 Jul; 21(4):411-8. PubMed ID: 11455530
[TBL] [Abstract][Full Text] [Related]
36. End-stage renal disease in Indonesia: treatment development.
Prodjosudjadi W; Suhardjono A
Ethn Dis; 2009; 19(1 Suppl 1):S1-33-6. PubMed ID: 19484872
[TBL] [Abstract][Full Text] [Related]
37. Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care.
Manns B; Meltzer D; Taub K; Donaldson C
Health Econ; 2003 Nov; 12(11):949-58. PubMed ID: 14601157
[TBL] [Abstract][Full Text] [Related]
38. [Kidney dialysis and transplantation].
Makó J
Orv Hetil; 2000 Dec; 141(50):2749. PubMed ID: 11189682
[No Abstract] [Full Text] [Related]
39. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
Hörl WH; de Alvaro F; Williams PF
Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
[TBL] [Abstract][Full Text] [Related]
40. Management of end stage renal disease (ESRD) -- the debate continues.
Feng PH
Singapore Med J; 1982 Feb; 23(1):1-2. PubMed ID: 7112134
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
